Bone-Induced Expression of Integrin Β3 Enables Targeted Nanotherapy of Breast Cancer Metastases

Cancer Research - United States
doi 10.1158/0008-5472.can-17-1225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Increased Dickkopf-1 Expression in Breast Cancer Bone Metastases

British Journal of Cancer
Cancer ResearchOncology
2007English

High Expression of Integrin Αvβ3 Enables Uptake of Targeted Fluorescent Probes Into Ovarian Cancer Cells and Tumors

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2018English

Targeted Treatments of Bone Metastases in Patients With Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2014English

Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast Cancer

Cancer Research
Cancer ResearchOncology
2007English

Strategies for Treatment of Bone Metastases From Breast Cancer

2005English

Bone-Targeted Therapies in Cancer-Induced Bone Disease

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2017English

Guideline Adherence in Bone-Targeted Treatment of Cancer Patients With Bone Metastases in Germany

Supportive Care in Cancer
Oncology
2019English

Expression of Selected Proteins in Breast Cancer Brain Metastases

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2013English

Analysis of Orthopedic Surgery of Bone Metastases in Breast Cancer Patients

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy